Raising Money for
Migraine news this week: May 14
Catch up on the headlines.Higher folate diet may reduce migraine frequency
Research has shown that taking folic acid supplements could help reduce migraine frequency, but it wasn’t known whether a diet rich in folates could provide the same help. MRF grantee Dr. Lyn Griffiths investigated and confirmed that women who had more folate in their diets had fewer migraines. Dark green vegetables, including broccoli, asparagus, and leaves like spinach and collard greens are some of the best dietary sources of folate.
Migraine Preventive Medicine: Research Update
Headache doctor Huma U. Sheikh reviewed three recently published headache research projects and discussed their real-life application. One study found that there’s a lack of evidence linking migraine to patent foramen ovale–a hole in the heart that didn’t close the way it should after birth–concluding there is not enough support to recommend the PFO closure surgery to migraine sufferers. This will help sufferers avoid unnecessary heart surgery. Another study highlighted the strong connection between migraine and co-morbid anxiety and depression. She reminded us that though this may seem obvious, it’s strong evidence to reinforce the developing focus on holistic, comprehensive headache treatment. The third study Dr. Sheikh reviewed summarized safe and effective medications for migraine in children.
$7 Million Research Funding Award for Migraine Research
Mayo Clinic in Phoenix officially announced the large migraine research grant they were awarded by the federal government. PCORI, the federal Patient-Centered Outcomes Research Institute, awarded a $7 million grant to MRF Medical Advisory Board Member Dr. Todd Schwedt to investigate treatment strategies for chronic migraine with medication overuse.
MRF is a member of the steering committee for this grant and will be integrally involved with all aspects of the study.
Migraine Drugs Underused
Triptans and DHE have long been believed to be unsafe for people with cardiovascular risk factors, but researchers analyzed past studies and found that may not be true. More research is needed, but if this is confirmed there may be more treatment options for over 10 million migraine sufferers.